Pharmchem Stock Fundamentals
| PCHM Stock | USD 3.10 0.00 0.00% |
PharmChem fundamentals help investors to digest information that contributes to PharmChem's financial success or failures. It also enables traders to predict the movement of PharmChem Pink Sheet. The fundamental analysis module provides a way to measure PharmChem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PharmChem pink sheet.
PharmChem |
PharmChem Company Return On Equity Analysis
PharmChem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PharmChem Return On Equity | -0.24 |
Most of PharmChem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PharmChem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, PharmChem has a Return On Equity of -0.2367. This is 99.01% lower than that of the Health Care Providers & Services sector and 96.46% lower than that of the Health Care industry. The return on equity for all United States stocks is 23.65% lower than that of the firm.
PharmChem Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PharmChem's current stock value. Our valuation model uses many indicators to compare PharmChem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PharmChem competition to find correlations between indicators driving PharmChem's intrinsic value. More Info.PharmChem is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmChem's earnings, one of the primary drivers of an investment's value.PharmChem Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PharmChem's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PharmChem could also be used in its relative valuation, which is a method of valuing PharmChem by comparing valuation metrics of similar companies.PharmChem is currently under evaluation in return on equity category among its peers.
PharmChem Fundamentals
| Return On Equity | -0.24 | |||
| Return On Asset | -0.0537 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 17.56 K | |||
| Price To Earning | (2.30) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0006 X | |||
| Revenue | 26.45 M | |||
| Gross Profit | 5.86 M | |||
| Net Income | (2.15 M) | |||
| Cash And Equivalents | 626 K | |||
| Cash Per Share | 0.11 X | |||
| Debt To Equity | 0.37 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | 1.30 X | |||
| Earnings Per Share | (0.35) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.15 | |||
| Market Capitalization | 17.55 K | |||
| Total Asset | 16.66 M | |||
| Retained Earnings | (10.28 M) | |||
| Working Capital | 1.28 M | |||
| Current Asset | 6.8 M | |||
| Current Liabilities | 5.52 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 4.60 % | |||
| Net Asset | 16.66 M |
About PharmChem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PharmChem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PharmChem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PharmChem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.